22 February 2018
News and Views
Links and Services
This month's Alimentary Pharmacology & Therapeutics examines the pharmacokinetics of adalimumab in Crohn's disease in the first 6 months of treatment.
Adalimumab is an effective therapy for Crohn's disease patients.
However, there is limited
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors